XIAOMING JIA to Treatment Outcome
This is a "connection" page, showing publications XIAOMING JIA has written about Treatment Outcome.
Connection Strength
0.337
-
Use of Early Intravenous Beta Blockers in Patients with Acute ST-Segment Elevation Myocardial Infarction Without Heart Failure-Revival or Requiem? Cardiovasc Drugs Ther. 2024 Oct; 38(5):973-975.
Score: 0.054
-
Practice patterns for patients with ST-elevation myocardial infarction during the early phase of the COVID-19 pandemic-Valuable lessons learned. Catheter Cardiovasc Interv. 2021 08 01; 98(2):223-224.
Score: 0.043
-
Impact of Lipid Monitoring on Treatment Intensification of Cholesterol Lowering Therapies (from the Veterans Affairs Healthcare System). Am J Cardiol. 2020 03 15; 125(6):874-879.
Score: 0.039
-
Eligibility and Cost for Icosapent Ethyl Based on the REDUCE-IT Trial. Circulation. 2019 03 05; 139(10):1341-1343.
Score: 0.037
-
Omega-3 Fatty Acid and Cardiovascular Outcomes: Insights From Recent Clinical Trials. Curr Atheroscler Rep. 2019 01 10; 21(1):1.
Score: 0.036
-
Poststatin Lipid Therapeutics: A Review. Methodist Debakey Cardiovasc J. 2019 Jan-Mar; 15(1):32-38.
Score: 0.036
-
SGLT2 Inhibitors and Cardiovascular Outcomes: Current Perspectives and Future Potentials. Curr Diab Rep. 2018 07 11; 18(9):63.
Score: 0.035
-
GLP-1 Receptor Agonists and Cardiovascular Disease: a Meta-Analysis of Recent Cardiac Outcome Trials. Cardiovasc Drugs Ther. 2018 02; 32(1):65-72.
Score: 0.034
-
Meta-Analysis of Randomized Trials Comparing Distal Transradial Versus Conventional Transradial Approach for Coronary Procedures. Am J Cardiol. 2022 06 15; 173:147-149.
Score: 0.011
-
Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombus: A Retrospective, Multicenter Study and Meta-Analysis of Existing Data. J Cardiovasc Pharmacol Ther. 2021 03; 26(2):173-178.
Score: 0.010